Wird geladen...
Therapeutic strategies for acute intermittent porphyria
Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by mutations in porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Symptoms of AIP usually manifest as intermittent acute attacks with occasional neuropsychiatric crises. The management of AIP i...
Gespeichert in:
| Veröffentlicht in: | Intractable Rare Dis Res |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7586882/ https://ncbi.nlm.nih.gov/pubmed/33139979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03089 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|